Obesity and endocrine therapy resistance in breast cancer: Mechanistic insights and perspectives
出版年份 2021 全文链接
标题
Obesity and endocrine therapy resistance in breast cancer: Mechanistic insights and perspectives
作者
关键词
-
出版物
Obesity Reviews
Volume 23, Issue 2, Pages -
出版商
Wiley
发表日期
2021-09-25
DOI
10.1111/obr.13358
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- FASN inhibition as a potential treatment for endocrine-resistant breast cancer
- (2021) Aleksandra Gruslova et al. BREAST CANCER RESEARCH AND TREATMENT
- Cyclin-dependent kinase 4 and 6 inhibitors for hormone receptor-positive breast cancer: past, present, and future
- (2020) Laura M Spring et al. LANCET
- Evaluation of SPP1/osteopontin expression as predictor of recurrence in tamoxifen treated breast cancer
- (2020) Anna Göthlin Eremo et al. Scientific Reports
- Adipocytes in Breast Cancer, the Thick and the Thin
- (2020) Ilona Rybinska et al. Cells
- Computed tomography-based analyses of baseline body composition parameters and changes in breast cancer patients under treatment with CDK 4/6 inhibitors
- (2020) Maria Alice Franzoi et al. BREAST CANCER RESEARCH AND TREATMENT
- Overcoming Endocrine Resistance in Breast Cancer
- (2020) Ariella B. Hanker et al. CANCER CELL
- The NFκB Pathway Promotes Tamoxifen Tolerance and Disease Recurrence in Estrogen Receptor–Positive Breast Cancers
- (2020) Irida Kastrati et al. MOLECULAR CANCER RESEARCH
- Leptin Signaling Contributes to Aromatase Inhibitor Resistant Breast Cancer Cell Growth and Activation of Macrophages
- (2020) Luca Gelsomino et al. Biomolecules
- Fasting-mimicking diet and hormone therapy induce breast cancer regression
- (2020) Irene Caffa et al. NATURE
- Obesity and Breast Cancer: A Case of Inflamed Adipose Tissue
- (2020) Ryan Kolb et al. Cancers
- Cholesterol and Mevalonate: Two Metabolites Involved in Breast Cancer Progression and Drug Resistance through the ERRα Pathway
- (2020) Matteo Brindisi et al. Cells
- Fatty Acid Synthase Is a Key Enabler for Endocrine Resistance in Heregulin-Overexpressing Luminal B-Like Breast Cancer
- (2020) Javier A. Menendez et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Evidence for Enhanced Exosome Production in Aromatase Inhibitor-Resistant Breast Cancer Cells
- (2020) Giuseppina Augimeri et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Extracellular matrix-bound FGF2 mediates estrogen receptor signaling and therapeutic response in breast cancer
- (2020) Josh W. DiGiacomo et al. MOLECULAR CANCER RESEARCH
- Obesity, Leptin and Breast Cancer: Epidemiological Evidence and Proposed Mechanisms
- (2019) Sebastiano Andò et al. Cancers
- Tumor-Associated Macrophages Induce Endocrine Therapy Resistance in ER+ Breast Cancer Cells
- (2019) Andrés M. Castellaro et al. Cancers
- Aberrant fatty acid profile and FFAR4 signaling confer endocrine resistance in breast cancer
- (2019) Xiao Chu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Insulin Receptor Associates with Promoters Genome-wide and Regulates Gene Expression
- (2019) Melissa L. Hancock et al. CELL
- Mammary adipose stromal cells derived from obese women reduce sensitivity to the aromatase inhibitor anastrazole in an organotypic breast model
- (2019) Molly M. Morgan et al. FASEB JOURNAL
- Obesity: an heavyweight player in breast cancer’s chemoresistance
- (2019) Charlotte Vaysse et al. Oncotarget
- Preventive drug therapy and contralateral breast cancer: summary of the evidence of clinical trials and observational studies
- (2019) Annet Bens et al. ACTA ONCOLOGICA
- Heat-health action plans in Europe: Challenges ahead and how to tackle them
- (2019) Gerardo S. Martinez et al. ENVIRONMENTAL RESEARCH
- Cancer-associated adipocytes: key players in breast cancer progression
- (2019) Qi Wu et al. Journal of Hematology & Oncology
- Dynamic interactions between the extracellular matrix and estrogen activity in progression of ER+ breast cancer
- (2019) Fatou Jallow et al. ONCOGENE
- The weight of obesity in breast cancer progression and metastasis: Clinical and molecular perspectives
- (2019) Ines Barone et al. SEMINARS IN CANCER BIOLOGY
- Hormonal Therapy Resistance and Breast Cancer: Involvement of Adipocytes and Leptin
- (2019) Laetitia Delort et al. Nutrients
- Tumor‐associated macrophages secrete CC‐chemokine ligand 2 and induce tamoxifen resistance by activating PI3K/Akt/mTOR in breast cancer
- (2019) Dongbo Li et al. CANCER SCIENCE
- Use of anastrozole for breast cancer prevention (IBIS-II): long-term results of a randomised controlled trial
- (2019) Jack Cuzick et al. LANCET
- Modulation of the leptin receptors expression in breast cancer cell lines exposed to leptin and tamoxifen
- (2019) Rodolfo López Linares et al. Scientific Reports
- Obesity as risk factor for subtypes of breast cancer: results from a prospective cohort study
- (2018) Cina J. Nattenmüller et al. BMC CANCER
- Impact of body mass index on the efficacy of endocrine therapy in patients with metastatic breast cancer - A retrospective two-center cohort study
- (2018) Luwam Zewenghiel et al. BREAST
- Increasing preoperative body size in breast cancer patients between 2002 and 2016: implications for prognosis
- (2018) Agatha Wisse et al. CANCER CAUSES & CONTROL
- Fibronectin rescues estrogen receptor α from lysosomal degradation in breast cancer cells
- (2018) Rocío G. Sampayo et al. JOURNAL OF CELL BIOLOGY
- Statins: a role in breast cancer therapy?
- (2018) S. Borgquist et al. JOURNAL OF INTERNAL MEDICINE
- IGF1R signaling drives antiestrogen resistance through PAK2/PIX activation in luminal breast cancer
- (2018) Yinghui Zhang et al. ONCOGENE
- Adipocyte/breast cancer cell crosstalk in obesity interferes with the anti-proliferative efficacy of tamoxifen
- (2018) Lauriane Bougaret et al. PLoS One
- Detection and localization of surgically resectable cancers with a multi-analyte blood test
- (2018) Joshua D. Cohen et al. SCIENCE
- The Impact of Obesity on Breast Cancer
- (2018) Daniel F. Argolo et al. Current Oncology Reports
- CDK6 inhibits white to beige fat transition by suppressing RUNX1
- (2018) Xiaoli Hou et al. Nature Communications
- Association of tamoxifen resistance and lipid reprogramming in breast cancer
- (2018) Susanne Hultsch et al. BMC CANCER
- Breast Cancer: Metastasis, Molecular Subtypes, and Overweight and Obesity in Veracruz, Mexico
- (2018) Carlos Adrián Alarcón Rojas et al. Clinical Breast Cancer
- Molecular mechanisms of resistance to CDK4/6 inhibitors in breast cancer: A review
- (2018) Kamal Pandey et al. INTERNATIONAL JOURNAL OF CANCER
- Crosstalk between Estrogen Signaling and Breast Cancer Metabolism
- (2018) Eylem Kulkoyluoglu-Cotul et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Identification of a gene signature for different stages of breast cancer development that could be used for early diagnosis and specific therapy
- (2018) Charu Kothari et al. Oncotarget
- Structural and Molecular Mechanisms of Cytokine-Mediated Endocrine Resistance in Human Breast Cancer Cells
- (2017) Joshua D. Stender et al. MOLECULAR CELL
- The RB–IL-6 axis controls self-renewal and endocrine therapy resistance by fine-tuning mitochondrial activity
- (2017) S Kitajima et al. ONCOGENE
- Glucose impairs tamoxifen responsiveness modulating connective tissue growth factor in breast cancer cells
- (2017) Maria Rosaria Ambrosio et al. Oncotarget
- Anthropometric, clinical and molecular determinants of treatment outcomes in postmenopausal, hormone receptor positive metastatic breast cancer patients treated with fulvestrant: Results from a real word setting
- (2017) Laura Pizzuti et al. Oncotarget
- Combined effect of obesity and diabetes on early breast cancer outcome: a prospective observational study
- (2017) Giuseppe Buono et al. Oncotarget
- Higher rate of severe toxicities in obese patients receiving dose-dense (dd) chemotherapy according to unadjusted body surface area: results of the prospectively randomized GAIN study
- (2016) J. Furlanetto et al. ANNALS OF ONCOLOGY
- Osteopontin splice variants are differential predictors of breast cancer treatment responses
- (2016) Krzysztof Zduniak et al. BMC CANCER
- Endocrine resistance in hormone-responsive breast cancer: mechanisms and therapeutic strategies
- (2016) Conleth G Murphy et al. ENDOCRINE-RELATED CANCER
- Disruption of insulin receptor function inhibits proliferation in endocrine-resistant breast cancer cells
- (2016) J Y Chan et al. ONCOGENE
- Body Mass Index and Clinical Benefit of Fulvestrant in Postmenopausal Women with Advanced Breast Cancer
- (2016) Arpine Gevorgyan et al. TUMORI
- Self-renewal of CD133hi cells by IL6/Notch3 signalling regulates endocrine resistance in metastatic breast cancer
- (2016) Pasquale Sansone et al. Nature Communications
- Leptin promotes migration and invasion of breast cancer cells by stimulating IL-8 production in M2 macrophages
- (2016) Hong Cao et al. Oncotarget
- Endocrine therapy for breast cancer prevention in high-risk women: clinical and economic considerations
- (2016) Amy G. Groom et al. Expert Review of Pharmacoeconomics & Outcomes Research
- Prognostic Value of Osteopontin Splice Variant-c Expression in Breast Cancers: A Meta-Analysis
- (2016) Chengcheng Hao et al. Biomed Research International
- Body Mass Index and Clinical Benefit of Fulvestrant in Postmenopausal Women with Advanced Breast Cancer
- (2016) Arpine Gevorgyan et al. TUMORI JOURNAL
- Impact of the Obesity Epidemic on Cancer
- (2015) Pamela J. Goodwin et al. Annual Review of Medicine
- Chronic oxidative stress causes estrogen-independent aggressive phenotype, and epigenetic inactivation of estrogen receptor alpha in MCF-7 breast cancer cells
- (2015) Prathap Kumar S. Mahalingaiah et al. BREAST CANCER RESEARCH AND TREATMENT
- Socioeconomic deprivation and inpatient complication rates following mastectomy and breast reconstruction surgery
- (2015) R. Jeevan et al. BRITISH JOURNAL OF SURGERY
- Overall and central adiposity and breast cancer risk in the sister study
- (2015) Alexandra J. White et al. CANCER
- Transcriptomic Profiling of Sequential Tumors from Breast Cancer Patients Provides a Global View of Metastatic Expression Changes Following Endocrine Therapy
- (2015) J. McBryan et al. CLINICAL CANCER RESEARCH
- A nude mouse model of obesity to study the mechanisms of resistance to aromatase inhibitors
- (2015) Amanda Schech et al. ENDOCRINE-RELATED CANCER
- CDK4 is an essential insulin effector in adipocytes
- (2015) Sylviane Lagarrigue et al. JOURNAL OF CLINICAL INVESTIGATION
- Estrogen receptor alpha mediates epithelial to mesenchymal transition, expression of specific matrix effectors and functional properties of breast cancer cells
- (2015) Panagiotis Bouris et al. MATRIX BIOLOGY
- Integration of Downstream Signals of Insulin-like Growth Factor-1 Receptor by Endoplasmic Reticulum Stress for Estrogen-Induced Growth or Apoptosis in Breast Cancer Cells
- (2015) P. Fan et al. MOLECULAR CANCER RESEARCH
- Aromatase Inhibitor-Mediated Downregulation of INrf2 (Keap1) Leads to Increased Nrf2 and Resistance in Breast Cancer
- (2015) R. Khatri et al. MOLECULAR CANCER THERAPEUTICS
- The impact of tumor stroma on drug response in breast cancer
- (2015) Jürgen Dittmer et al. SEMINARS IN CANCER BIOLOGY
- ObRb downregulation increases breast cancer cell sensitivity to tamoxifen
- (2015) Yingying Qian et al. TUMOR BIOLOGY
- Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasion
- (2015) Van T. M. Nguyen et al. Nature Communications
- Basal and therapy-driven hypoxia-inducible factor-1α confers resistance to endocrine therapy in estrogen receptor-positive breast
- (2015) Xiaoqing Jia et al. Oncotarget
- Overweight, Obesity, and Postmenopausal Invasive Breast Cancer Risk
- (2015) Marian L. Neuhouser et al. JAMA Oncology
- Upregulation of IGF-1R Expression during Neoadjuvant Therapy Predicts Poor Outcome in Breast Cancer Patients
- (2015) Sandra Heskamp et al. PLoS One
- Obesity and the outcome of young breast cancer patients in the UK: the POSH study
- (2014) E. R. Copson et al. ANNALS OF ONCOLOGY
- Biomarker changes associated with the development of resistance to aromatase inhibitors (AIs) in estrogen receptor-positive breast cancer
- (2014) M. Arnedos et al. ANNALS OF ONCOLOGY
- Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies
- (2014) D. S. M. Chan et al. ANNALS OF ONCOLOGY
- Association between insulin-like growth factor-1 receptor (IGF1R) negativity and poor prognosis in a cohort of women with primary breast cancer
- (2014) Kristina E Aaltonen et al. BMC CANCER
- AR collaborates with ERα in aromatase inhibitor-resistant breast cancer
- (2014) Yassine Rechoum et al. BREAST CANCER RESEARCH AND TREATMENT
- Breast edema in breast cancer patients following breast-conserving surgery and radiotherapy: a systematic review
- (2014) Hanne Verbelen et al. BREAST CANCER RESEARCH AND TREATMENT
- BMI variation increases recurrence risk in women with early-stage breast cancer
- (2014) Palma Fedele et al. Future Oncology
- Healthy lifestyle and risk of breast cancer among postmenopausal women in the European Prospective Investigation into Cancer and Nutrition cohort study
- (2014) Fiona McKenzie et al. INTERNATIONAL JOURNAL OF CANCER
- American Society of Clinical Oncology Position Statement on Obesity and Cancer
- (2014) Jennifer A. Ligibel et al. JOURNAL OF CLINICAL ONCOLOGY
- Effects of Obesity on Transcriptomic Changes and Cancer Hallmarks in Estrogen Receptor–Positive Breast Cancer
- (2014) Enrique Fuentes-Mattei et al. JNCI-Journal of the National Cancer Institute
- Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5·24 million UK adults
- (2014) Krishnan Bhaskaran et al. LANCET
- Statins and breast cancer prognosis: evidence and opportunities
- (2014) Thomas P Ahern et al. LANCET ONCOLOGY
- Tumor-Associated Macrophages are Correlated with Tamoxifen Resistance in the Postmenopausal Breast Cancer Patients
- (2014) Qi-jia Xuan et al. PATHOLOGY & ONCOLOGY RESEARCH
- Venous Thromboembolism Risk in Mastectomy and Immediate Breast Reconstruction
- (2014) John P. Fischer et al. PLASTIC AND RECONSTRUCTIVE SURGERY
- Synergy of leptin/STAT3 with HER2 receptor induces tamoxifen resistance in breast cancer cells through regulation of apoptosis-related genes
- (2014) Vassilis Papanikolaou et al. CELLULAR ONCOLOGY
- Gene expression differences in adipose tissue associated with breast tumorigenesis
- (2014) Lori A Sturtz et al. Adipocyte
- Obesity, diabetes, and survival outcomes in a large cohort of early-stage breast cancer patients
- (2013) S. Jiralerspong et al. ANNALS OF ONCOLOGY
- Thioredoxin-mediated redox regulation of resistance to endocrine therapy in breast cancer
- (2013) Rosalind Brigham Penney et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Extracellular matrix components in breast cancer progression and metastasis
- (2013) Thordur Oskarsson BREAST
- Efficacy of tamoxifen±aminoglutethimide in normal weight and overweight postmenopausal patients with hormone receptor-positive breast cancer: an analysis of 1509 patients of the ABCSG-06 trial
- (2013) G Pfeiler et al. BRITISH JOURNAL OF CANCER
- The predictive impact of body mass index on the efficacy of extended adjuvant endocrine treatment with anastrozole in postmenopausal patients with breast cancer: an analysis of the randomised ABCSG-6a trial
- (2013) M Gnant et al. BRITISH JOURNAL OF CANCER
- Cellular Fatty Acid Metabolism and Cancer
- (2013) Erin Currie et al. Cell Metabolism
- Molecular Profiling of Aromatase Inhibitor-Treated Postmenopausal Breast Tumors Identifies Immune-Related Correlates of Resistance
- (2013) A. K. Dunbier et al. CLINICAL CANCER RESEARCH
- Body Mass Index and Breast Cancer Risk According to Postmenopausal Estrogen-Progestin Use and Hormone Receptor Status
- (2013) Mark F. Munsell et al. EPIDEMIOLOGIC REVIEWS
- Inhibition of c-Src blocks oestrogen-induced apoptosis and restores oestrogen-stimulated growth in long-term oestrogen-deprived breast cancer cells
- (2013) Ping Fan et al. EUROPEAN JOURNAL OF CANCER
- Leptin as a Potential Target for Estrogen Receptor-Positive Breast Cancer
- (2013) Cha Kyong Yom et al. Journal of Breast Cancer
- Impact of Obesity on Outcomes in Breast Reconstruction: Analysis of 15,937 Patients from the ACS-NSQIP Datasets
- (2013) John P. Fischer et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis
- (2013) Tracey DiSipio et al. LANCET ONCOLOGY
- Minireview: Obesity and Breast Cancer: A Tale of Inflammation and Dysregulated Metabolism
- (2013) Evan R. Simpson et al. MOLECULAR ENDOCRINOLOGY
- Pathophysiology of Human Visceral Obesity: An Update
- (2013) André Tchernof et al. PHYSIOLOGICAL REVIEWS
- Breast Cancer and Obesity: In Vitro Interferences between Adipokines and Proangiogenic Features and/or Antitumor Therapies?
- (2013) Virginie Dubois et al. PLoS One
- Phosphorylation of estrogen receptor α at serine 118 is correlated with breast cancer resistance to tamoxifen
- (2013) MING CHEN et al. Oncology Letters
- Re-thinking cell cycle regulators: the cross-talk with metabolism
- (2013) Lluis Fajas Frontiers in Oncology
- Cytokines, Obesity, and Cancer: New Insights on Mechanisms Linking Obesity to Cancer Risk and Progression
- (2012) Candace A. Gilbert et al. Annual Review of Medicine
- Leptin attenuates the anti-estrogen effect of tamoxifen in breast cancer
- (2012) Xiaofeng Chen et al. BIOMEDICINE & PHARMACOTHERAPY
- NFκB signaling is important for growth of antiestrogen resistant breast cancer cells
- (2012) Christina W. Yde et al. BREAST CANCER RESEARCH AND TREATMENT
- Inhibition of the proliferation of acquired aromatase inhibitor-resistant breast cancer cells by histone deacetylase inhibitor LBH589 (panobinostat)
- (2012) Makoto Kubo et al. BREAST CANCER RESEARCH AND TREATMENT
- Excess body weight and second primary cancer risk after breast cancer: a systematic review and meta-analysis of prospective studies
- (2012) Nathalie Druesne-Pecollo et al. BREAST CANCER RESEARCH AND TREATMENT
- Efficacy of adjuvant aromatase inhibitor in hormone receptor-positive postmenopausal breast cancer patients according to the body mass index
- (2012) M A N Sendur et al. BRITISH JOURNAL OF CANCER
- AACR Cancer Progress Report 2012
- (2012) CLINICAL CANCER RESEARCH
- Estrogens and PTP1B Function in a Novel Pathway to Regulate Aromatase Enzymatic Activity in Breast Cancer Cells
- (2012) Ines Barone et al. ENDOCRINOLOGY
- Obesity and Risk of Recurrence or Death After Adjuvant Endocrine Therapy With Letrozole or Tamoxifen in the Breast International Group 1-98 Trial
- (2012) Marianne Ewertz et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeting Insulin and Insulin-Like Growth Factor Signaling in Breast Cancer
- (2012) Yuzhe Yang et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Leptin increases HER2 protein levels through a STAT3-mediated up-regulation of Hsp90 in breast cancer cells
- (2012) Cinzia Giordano et al. Molecular Oncology
- Effect of Body Mass Index on Breast Cancer during Premenopausal and Postmenopausal Periods: A Meta-Analysis
- (2012) Zahra Cheraghi et al. PLoS One
- Increased Levels of COX-2 and Prostaglandin E 2 Contribute to Elevated Aromatase Expression in Inflamed Breast Tissue of Obese Women
- (2012) Kotha Subbaramaiah et al. Cancer Discovery
- Inflammatory Mechanisms in Obesity
- (2011) Margaret F. Gregor et al. Annual Review of Immunology
- Relationship between body mass index and preoperative treatment response to aromatase inhibitor exemestane in postmenopausal patients with primary breast cancer
- (2011) Masahiro Takada et al. BREAST
- Endocrine therapy in obese patients with primary breast cancer: another piece of evidence in an unfinished puzzle
- (2011) R. Wolters et al. BREAST CANCER RESEARCH AND TREATMENT
- The tumor microenvironment modulates tamoxifen resistance in breast cancer: a role for soluble stromal factors and fibronectin through β1 integrin
- (2011) Osvaldo Pontiggia et al. BREAST CANCER RESEARCH AND TREATMENT
- Inflammation and Increased Aromatase Expression Occur in the Breast Tissue of Obese Women with Breast Cancer
- (2011) Patrick G. Morris et al. Cancer Prevention Research
- Obesity Is Associated with Inflammation and Elevated Aromatase Expression in the Mouse Mammary Gland
- (2011) K. Subbaramaiah et al. Cancer Prevention Research
- A Kinome-Wide Screen Identifies the Insulin/IGF-I Receptor Pathway as a Mechanism of Escape from Hormone Dependence in Breast Cancer
- (2011) E. M. Fox et al. CANCER RESEARCH
- Chronic Leptin Treatment Sensitizes MCF-7 Breast Cancer Cells to Estrogen
- (2011) Adamo Valle et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- A New Molecular Predictor of Distant Recurrence in ER-Positive, HER2-Negative Breast Cancer Adds Independent Information to Conventional Clinical Risk Factors
- (2011) Martin Filipits et al. CLINICAL CANCER RESEARCH
- Therapeutically activating RB: reestablishing cell cycle control in endocrine therapy-resistant breast cancer
- (2011) C. Thangavel et al. ENDOCRINE-RELATED CANCER
- Osteopontin Is an Activator of Human Adipose Tissue Macrophages and Directly Affects Adipocyte Function
- (2011) Maximilian Zeyda et al. ENDOCRINOLOGY
- Impact of Body Mass Index on the Efficacy of Endocrine Therapy in Premenopausal Patients With Breast Cancer: An Analysis of the Prospective ABCSG-12 Trial
- (2011) Georg Pfeiler et al. JOURNAL OF CLINICAL ONCOLOGY
- Exemestane for Breast-Cancer Prevention in Postmenopausal Women
- (2011) Paul E. Goss et al. NEW ENGLAND JOURNAL OF MEDICINE
- An “Omics” Approach to Determine the Mechanisms of Acquired Aromatase Inhibitor Resistance
- (2011) Shiuan Chen OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY
- Large breast size as a risk factor for late adverse effects of breast radiotherapy: Is residual dose inhomogeneity, despite 3D treatment planning and delivery, the main explanation?
- (2011) Christy Goldsmith et al. RADIOTHERAPY AND ONCOLOGY
- Aromatase, breast cancer and obesity: a complex interaction
- (2011) Serdar E. Bulun et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Adult weight gain in relation to breast cancer risk by estrogen and progesterone receptor status: a meta-analysis
- (2010) Alina Vrieling et al. BREAST CANCER RESEARCH AND TREATMENT
- Increased risk of contralateral breast cancers among overweight and obese women: a time-dependent association
- (2010) Bilal Majed et al. BREAST CANCER RESEARCH AND TREATMENT
- Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis
- (2010) Melinda Protani et al. BREAST CANCER RESEARCH AND TREATMENT
- Cytokine Receptor CXCR4 Mediates Estrogen-Independent Tumorigenesis, Metastasis, and Resistance to Endocrine Therapy in Human Breast Cancer
- (2010) Lyndsay V. Rhodes et al. CANCER RESEARCH
- Estrogen Receptor Mutations and Changes in Downstream Gene Expression and Signaling
- (2010) I. Barone et al. CLINICAL CANCER RESEARCH
- Cycling through metabolism
- (2010) Victor Aguilar et al. EMBO Molecular Medicine
- BCL2 and CASP8 regulation by NF-κB differentially affect mitochondrial function and cell fate in antiestrogen-sensitive and -resistant breast cancer cells
- (2010) Ruchi Nehra et al. FASEB JOURNAL
- Oxidative stress, inflammation, and cancer: How are they linked?
- (2010) Simone Reuter et al. FREE RADICAL BIOLOGY AND MEDICINE
- Effect of Body Mass Index on Recurrences in Tamoxifen and Anastrozole Treated Women: An Exploratory Analysis From the ATAC Trial
- (2010) Ivana Sestak et al. JOURNAL OF CLINICAL ONCOLOGY
- Energy Balance, Host-Related Factors, and Cancer Progression
- (2010) Stephen D. Hursting et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of Obesity on Prognosis After Early-Stage Breast Cancer
- (2010) Marianne Ewertz et al. JOURNAL OF CLINICAL ONCOLOGY
- Growth factor signaling enhances aromatase activity of breast cancer cells via post-transcriptional mechanisms
- (2010) Bin Su et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies
- (2010) Xiaohong R. Yang et al. JNCI-Journal of the National Cancer Institute
- Increased insulin-like growth factor-1 receptor mRNA expression predicts poor survival in immunophenotypes of early breast carcinoma
- (2010) Gloria Peiró et al. MODERN PATHOLOGY
- Phosphorylation of the mutant K303R estrogen receptor α at serine 305 affects aromatase inhibitor sensitivity
- (2010) I Barone et al. ONCOGENE
- An ER activity profile including ER, PR, Bcl-2 and IGF-IR may have potential as selection criterion for letrozole or tamoxifen treatment of patients with advanced breast cancer
- (2009) Katrine L. Henriksen et al. ACTA ONCOLOGICA
- Shortened Survival and More Metastasis Recurrences among Overweight Breast Cancer Patients
- (2009) Bilal Majed et al. Breast Journal
- Obesity and poor breast cancer prognosis: an illusion because of hormone replacement therapy?
- (2009) L Rosenberg et al. BRITISH JOURNAL OF CANCER
- Expression of the K303R Estrogen Receptor- Breast Cancer Mutation Induces Resistance to an Aromatase Inhibitor via Addiction to the PI3K/Akt Kinase Pathway
- (2009) I. Barone et al. CANCER RESEARCH
- Appropriateness of waist circumference and waist-to-hip ratio cutoffs for different ethnic groups
- (2009) S A Lear et al. EUROPEAN JOURNAL OF CLINICAL NUTRITION
- Rapid Estradiol/ERα Signaling Enhances Aromatase Enzymatic Activity in Breast Cancer Cells
- (2009) Stefania Catalano et al. MOLECULAR ENDOCRINOLOGY
- Pre-diagnosis body mass index, post-diagnosis weight change, and prognosis among women with early stage breast cancer
- (2008) Bette J. Caan et al. CANCER CAUSES & CONTROL
- The inflammatory chemokines CCL2 and CCL5 in breast cancer
- (2008) Gali Soria et al. CANCER LETTERS
- Combination of Anastrozole with Fulvestrant in the Intratumoral Aromatase Xenograft Model
- (2008) L. F. Macedo et al. CANCER RESEARCH
- Association of an Extracellular Matrix Gene Cluster with Breast Cancer Prognosis and Endocrine Therapy Response
- (2008) J. Helleman et al. CLINICAL CANCER RESEARCH
- The Interleukin-8 Pathway in Cancer
- (2008) D. J.J. Waugh et al. CLINICAL CANCER RESEARCH
- Increased expression of Nrf2/ARE-dependent anti-oxidant proteins in tamoxifen-resistant breast cancer cells
- (2008) Sang Kyum Kim et al. FREE RADICAL BIOLOGY AND MEDICINE
- Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status-A meta-analysis
- (2008) Reiko Suzuki et al. INTERNATIONAL JOURNAL OF CANCER
- Insulin-Like Growth Factor-I Activates Gene Transcription Programs Strongly Associated With Poor Breast Cancer Prognosis
- (2008) Chad J. Creighton et al. JOURNAL OF CLINICAL ONCOLOGY
- Phosphorylated ERα, HIF-1α, and MAPK Signaling As Predictors of Primary Endocrine Treatment Response and Resistance in Patients With Breast Cancer
- (2008) Daniele Generali et al. JOURNAL OF CLINICAL ONCOLOGY
- Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies
- (2008) Andrew G Renehan et al. LANCET
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started